CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Breckenridge Pharmaceutial, Inc. vs. Novartis Pharmaceuticals Corporation

Explore the PTAB proceeding IPR2017-01592 filed by Breckenridge Pharmaceutial, Inc. on 2017-06-12. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2017-01592

Filing Date

2017-06-12

Accorded Filing Date

2017-06-12

Institution Decision Date

2018-01-03

Last Modified Date

2022-06-24

Proceeding Type

IPR

Termination Date

2019-06-03

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 10468520
Respondent Patent Number 8410131
Legal Expiration Date
2025-11-01 Expired (Term Ended)
Patent Term Adjustment (PTA) +1352 Days Awarded
Injunction Viability (35 U.S.C. ยง 283) Statutorily Barred
Respondent Inventor Heidi Lane et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Terminated-Settled

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Termination 2019-06-03
Termination Decision Document
37 CFR 42.5, 37 CFR 42.72, 37 CFR 42.74, 35 USC 317

Address and Attorney/Agent Information

32 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name NOVARTIS PHARMACEUTICAL CORPORATION - INTELLECTUAL PROPERTY DEPARTMENT
Customer Number โ€”
Address 250 Massachusetts Avenue, Cambridge, MA, 02139, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
39030 Jean Silveri +1 617-871-5134
40232 Timothy Witkowski +1 617-301-1869
43228 Peter Waibel +1 862-778-7838
46473 Emily Wu +1 858-812-1539
46593 Laurie Lawrence +1 617-871-8584
48631 Carol Fang +1 650-467-2901
51681 Mark Flanigan +1 817-615-5080
53504 Daniel Raymond +1 858-812-1617

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 13 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials Counterparts in force
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (13): GB ๐Ÿ‡บ๐Ÿ‡ธ US ๐ŸŒ PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

200
89

Termination Decision Document Paper

2019-06-03 FILING PARTY: BOARD
88

Patent Owner's Exhibit List 11 Paper

2019-05-23 FILING PARTY: PATENT OWN
86

Hikma and Novartis's Joint Motion To Treat Settlement Agreement (Ex. 2116) As Business Confidential Information Paper

2019-05-23 FILING PARTY: PATENT OWN
2117

Exhibit 2117 - Protective Order Exhibits

2019-05-23 FILING PARTY: PATENT OWN
85

Hikma and Novartis's Joint Motion To Terminate IPR Paper

2019-05-23 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc